XML 60 R44.htm IDEA: XBRL DOCUMENT v3.25.1
ORGANIZATION AND BASIS OF PRESENTATION (Tables)
12 Months Ended
Dec. 31, 2024
ORGANIZATION AND BASIS OF PRESENTATION  
Schedule of subsidiaries

Percentage of

Date of

Place of

ownership by

Entities

    

establishment/acquisition

    

establishment

    

the Company

    

Principal activities

Subsidiaries

 

  

 

  

 

  

 

  

Ascendium Group Limited (“Ascendium”)

September 10, 2007

 

British Virgin Islands (“BVI”)

 

100

%  

Investment holding

China Medical Services Holdings Limited (“CMS Holdings”)

July 18, 2008

 

Hong Kong

 

100

%  

Investment holding

Shenzhen Aohua Medical Technology Development Co., Ltd. (“Aohua Technology ”) **

February 21, 2008

 

PRC

 

39.77

%  

Leasing of medical equipment and provision of management services

Medstar (Shanghai) Enterprise Management Company Limited (“Shanghai Medstar”)

March 21, 2003

 

PRC

 

98.19

%  

Leasing of medical equipment and provision of management services

Concord Healthcare Group Co., Ltd. (“Concord Healthcare”) (formerly known as Meizhong Jiahe Medical Technology Development Group Co., Ltd.) *

July 23, 2008

 

PRC

 

39.77

%  

Provision of management services

Beijing Yundu Internet Technology Co., Ltd. (“Yundu”) **

July 26, 2007

 

PRC

 

39.77

%  

Provision of management services

Tianjin Concord Medical Technology Limited (“Tianjin Concord Medical”)

April 22, 2010

 

PRC

 

98.19

%  

Leasing of medical equipment and provision of management services

Guangzhou Concord Cancer Center Co., Ltd. (“Guangzhou Concord Cancer Hospital”) **

June 29, 2011

 

PRC

 

31.81

%  

Medical treatment and service business

CCM (Hong Kong) Medical Investments Limited (“CCM (HK)”)

June 03, 2013

 

Hong Kong

 

85.71

%  

Investment holding

Shanghai Concord Cancer Center Co., Ltd. (“SHC”) **

March 17, 2014

 

PRC

 

27.99

%  

Medical treatment and service business

Wuxi Concord Medical Development Ltd. (“Wuxi Concord”)

December 29, 2015

PRC

100

%  

Provision of management services

Percentage of  

Date of

Place of

ownership by

Entities

    

establishment/acquisition

    

establishment

    

the Company

    

Principal activities

Beijing Concord Medical Technology Ltd.(“BJCMT”)

January 4, 2016

 

PRC

 

100

%  

Provision of management services

Beijing Century Friendship Science & Technology Development Co., Ltd. (“Beijing Century Friendship”)**

October 8, 2018

PRC

98.19

%  

Provision of management services and investment holding

Beijing Proton Medical Center Co., Ltd. (“BPMC”)

October 8, 2018

 

PRC

 

54.01

%  

Medical treatment and service business

Shanghai Meizhong Jiahe Cancer Center Co., Ltd. (“CMCC”)**

October 8, 2018

 

PRC

 

29.50

%  

Medical treatment and service business

Shanghai Meizhong Jiahe Imaging Diagnostic Center Co., Ltd. (“SH MZJH”) **

November 18,2019

 

PRC

 

19.29

%  

Medical treatment and service business

Wuxi Meizhong Jiahe Cancer Center Co., Ltd. (“Wuxi MZJH”)

November 18,2019

 

PRC

 

95.22

%  

Medical treatment and service business

Yinchuan Meizhong Jiahe Internet Hospital Ltd. (“YCIH”) **

October 18, 2020

 

PRC

 

27.81

%  

Medical treatment and service business

US Proton Therapy Holdings Limited (“Proton BVI”)

May 16, 2011

 

BVI

 

100

%  

Investment holding

US Proton Therapy Holdings Limited (“US Proton”)

June 29, 2011

 

United States of America

 

100

%  

Investment holding

Beijing Healthingkon Technology Co., Ltd. (“Healthingkon”) (note 4) **

January 4, 2021

 

China

 

10.47

%  

Leasing of medical equipment and technical service

Guangzhou Concord Medical Technology Innovation Center Co., Ltd. (“GCMTIC”) **

April 22, 2021

 

China

 

39.77

%  

Technical service

*  On March 26, 2018, July 10, 2018 and on April 7, 2020, the Group entered into agreements with CICC Capital Management Company Limited (“CICC Capital”), a wholly-owned subsidiary of China International Capital Corporation Limited (“CICC”), together with six other investors (“Other Investors”) and CITIC Industrial Investment Group Limited (“CITIC Industrial”). Pursuant to the agreements, CICC Capital, Other Investors and CITIC Industrial make a strategic investment and subscribe new issued 60,000,000, 40,000,000 and 38,888,888 shares of the Group’s subsidiary Concord Healthcare, with total consideration of RMB1,500,000 and RMB700,000.

** Aohua Technology, Yundu, Guangzhou Concord Cancer Hospital, SHC, Beijing Century Friendship, CMCC, SH MZJH, YCIH, GCMTIC and Healthingkon are subsidiaries of Concord Healthcare.